The Foundation for Sarcoidosis Research (FSR) is pleased to announce the appointment of four new members to its Board of ...

In a study led by a multinational team of experts, researchers at National Jewish Health and their collaborators in Colorado, ...

Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing will ...

As the effects of wildfires persist in several parts of the United States, McGowan highlighted a public health alert ...

Sarcoidosis is a systemic inflammatory disorder of unknown etiology, characterized by the formation of noncaseating granulomas, multisystem involvement, intrathoracic (pulmonary and lymph node ...

After extensive examinations at Rabin Medical Center-Beilinson Campus, Petah Tikva, she was found to be suffering from a severe eye inflammation, the first manifestation of sarcoidosis.

Announcement coincides with Foundation’s 25th anniversary and recent FMLA clarification supporting clinical trial ...

In a groundbreaking study led by a multinational team of experts, researchers at National Jewish Health and their collaborators in Colorado, Illinois ...

Pulmonary sarcoidosis is a lung disease characterized by granulomas-tiny clumps of immune cells that form in response to inflammation. It's the most inflammatory of the interstitial lung diseases ...

Additionally, the evolving national disease registries lack information about sarcoidosis, and limited awareness among ...

SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) ("aTyr” or the "Company”), a clinical stage ...

CHICAGO, April 30, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) today celebrated the official recognition of April as Sarcoidosis Awareness Month in the U.S. House of ...